Treatment of Endometrial Hyperplasia With an Intrauterine Device (IUD)
Status and phase
Conditions
Treatments
Details and patient eligibility
About
The purpose of this research is to determine the effectiveness of the intrauterine device (IUD) called Mirena when compared to the Provera tablets used in treating this condition.
Full description
Endometrial hyperplasia without atypia is a condition usually caused by excessive stimulation of the uterine lining (endometrium) by estrogens, and may cause irregular bleeding as a presenting symptom, but rarely may progress to endometrial cancer, which makes treatment important. The only treatment approved so far is medroxyprogesterone acetate tablets (progesterone), also known as Provera.
Sex
Ages
Volunteers
Inclusion criteria
- Histologic diagnosis of simple or complex endometrial hyperplasia without atypia
- Normal pap smear within one year
Exclusion criteria
- Diabetes
- Family history of endometrial cancer
- Contraindications for the intrauterine device
Trial design
Primary purpose
Allocation
Interventional model
Masking
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal